March 2, 2011 - iPad App For EPCR Launches

ZOLL LAUNCHES IPAD APP FOR EPCR  

Emergency Response Teams Can Now Use iPad Technology to Complete Electronic Patient Care Reports

March 2, 2011─CHELMSFORD, MASS.–ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it has introduced an iPad™ app for EMS organizations to create electronic patient care reports (ePCRs).  

The new ZOLL RescueNet ePCR for iPad app will provide EMS organizations with critical data capture functionality, including time-stamping, auto calculations of age and mileage, auto populated narrative for an easier SOAP (subjective objective assessment and plan), and one-tap access to all data input screens. It also allows multi-agency login support, stylus-free signature capabilities, and the flagging of incomplete sections. The app brings intuitive, electronic iPad access to the patient care reporting process.  

“We are excited to be able to offer EMS professionals new technology to assist them in the life-saving situations they face every day. Our commitment is to offer applications that simplify data collection and improve access to information,” said David Brown, President, Data Management Products, ZOLL. ”We hope the operational and economical efficiencies our ePCR iPad solution provides will enable more EMS organizations to adopt electronic patient care reporting.”

The ZOLL ePCR iPad app will be available late May, 2011 to download from the iTunes^® store. The pricing model will include no charge for the app download and then a per run fee for ongoing usage. Ruggedized cases to give the iPad the necessary protection needed in emergency response environments are available from a variety of sources including the OtterBox^® Defender.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's  Annual  Report on Form 10-K filed with the SEC on December 17, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105.  PocketCPR, Real CPR Help and ZOLL are registered trademarks of ZOLL Medical Corporation in the United States and/or other countries.  All product names are the property of their respective owners.